Nan, Xinsheng
Hardinge, Patrick
Hoehn, Sven
Dighe, Shrinivas Nivrutti
Ukeri, John
Pease, Darius F.
Griffin, Joshua
Warrington, Jessica I.
Saud, Zack
Hottinger, Emma
Webster, Gordon
Jones, Davey
Kille, Peter
Weightman, Andrew
Stanton, Richard
Castell, Oliver K.
Murray, James A. H.
Jurkowski, Tomasz P.
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BB/W003562/1)
Ser Cymru Welsh Government (MA/KW/1457/20)
Welsh Government (WeWASH)
Cardiff University
Medical Research Council (MR/V028448/1)
Wellcome (204870/Z/16/Z)
Article History
Received: 4 August 2023
Accepted: 11 November 2023
First Online: 27 November 2023
Competing interests
: All the authors, with the exception of TPJ, declare that they have no competing interests. TPJ is a director and shareholder of a small biotech company, Magnacell Ltd which supplied the magnetic beads for the RNA extraction (BOMB protocol).